CN108392501A - 含野木瓜提取物的医药组合物 - Google Patents

含野木瓜提取物的医药组合物 Download PDF

Info

Publication number
CN108392501A
CN108392501A CN201810231572.9A CN201810231572A CN108392501A CN 108392501 A CN108392501 A CN 108392501A CN 201810231572 A CN201810231572 A CN 201810231572A CN 108392501 A CN108392501 A CN 108392501A
Authority
CN
China
Prior art keywords
extract
hot water
antipyretic
stauntonvine
leaf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201810231572.9A
Other languages
English (en)
Chinese (zh)
Inventor
崔徹雄
潘相吾
薛熙珍
李圭玉
朴嘉贤
金熙淑
张旭镇
金炫
李东旭
金善晤
金载甲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yungjin Pharmaceutical Co Ltd
Jeonnam Bioindustry Foundation
Original Assignee
Yungjin Pharmaceutical Co Ltd
Jeonnam Bioindustry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020110082023A external-priority patent/KR101167589B1/ko
Priority claimed from KR1020120038977A external-priority patent/KR101221617B1/ko
Priority claimed from KR1020120050532A external-priority patent/KR101243115B1/ko
Application filed by Yungjin Pharmaceutical Co Ltd, Jeonnam Bioindustry Foundation filed Critical Yungjin Pharmaceutical Co Ltd
Publication of CN108392501A publication Critical patent/CN108392501A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
CN201810231572.9A 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物 Pending CN108392501A (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
KR10-2011-0082023 2011-08-18
KR1020110082023A KR101167589B1 (ko) 2011-08-18 2011-08-18 멀꿀 열매 추출물을 포함하는 항염증제
KR1020120038977A KR101221617B1 (ko) 2012-04-16 2012-04-16 멀꿀 잎 추출물을 포함하는 항염증제
KR10-2012-0038977 2012-04-16
KR10-2012-0050532 2012-05-11
KR1020120050532A KR101243115B1 (ko) 2012-04-17 2012-05-11 멀꿀 잎 추출물을 포함하는 해열제
CN201280045043.0A CN103826651A (zh) 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CN201280045043.0A Division CN103826651A (zh) 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物

Publications (1)

Publication Number Publication Date
CN108392501A true CN108392501A (zh) 2018-08-14

Family

ID=50185141

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201810231572.9A Pending CN108392501A (zh) 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物
CN201280045043.0A Pending CN103826651A (zh) 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201280045043.0A Pending CN103826651A (zh) 2011-08-18 2012-05-16 含野木瓜提取物的医药组合物

Country Status (9)

Country Link
US (2) US9370542B2 (enExample)
EP (2) EP2774617B1 (enExample)
JP (2) JP6049721B2 (enExample)
CN (2) CN108392501A (enExample)
AU (2) AU2012295779A1 (enExample)
CA (2) CA2999174C (enExample)
ES (2) ES2752249T3 (enExample)
PL (2) PL3097920T3 (enExample)
WO (1) WO2013024960A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101532832B1 (ko) * 2013-06-30 2015-06-30 재단법인 전남생물산업진흥원 멀꿀 잎 추출물을 유효성분으로 포함하는 골조직 생성 촉진용 약학 조성물
US10137162B1 (en) * 2018-01-26 2018-11-27 King Saud University Gastroprotective extracts of Sonchus oleraceus L.
CN114053296A (zh) * 2021-11-28 2022-02-18 赣州安宏环保科技有限公司 近视眼提升视力的明目效果纳米气化胶及其制备方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01290694A (ja) * 1988-05-07 1989-11-22 Zhongguo Yixuekexueyuan Yaowo Yanjiusuo リグナン化合物
CN1562275A (zh) * 2004-03-22 2005-01-12 广州安健实业发展有限公司 野木瓜总甙及其注射剂
KR20110068923A (ko) * 2009-12-15 2011-06-22 재단법인 경기바이오센터 항히스타민제 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01242596A (ja) 1988-03-17 1989-09-27 Zhongguo Yixuekexueyuan Yaowo Yanjiusuo リグナン化合物
JP2001226249A (ja) * 2000-02-17 2001-08-21 Ichimaru Pharcos Co Ltd 植物水蒸気蒸留水含有化粧料組成物
CN1742816A (zh) 2005-10-07 2006-03-08 张益群 一种五角枫根外用药
CN100350932C (zh) 2005-12-27 2007-11-28 王赛 非手术治疗鼻炎、咽喉炎的药物
CN101024065A (zh) 2007-04-09 2007-08-29 林水文 一种活络油的药物组合物及其制备方法
CN101283784B (zh) 2007-09-27 2012-01-11 贵州大学 野木瓜保健固体饮料及其制备方法
KR100906696B1 (ko) 2007-11-12 2009-07-07 이스트힐(주) 오메가오일과 멀꿀나무 추출물을 포함하는 색조 화장료용 복합 분체
CN101879196A (zh) * 2009-05-08 2010-11-10 何国增 一种中药野木瓜注射液的制备方法
CN102132914A (zh) 2010-01-27 2011-07-27 遵义光勋绿色产业有限公司 一种野木瓜饮料的制备方法
CN101926488B (zh) * 2010-04-06 2012-05-23 贵州大学 一种野木瓜果醋饮料的制备方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01290694A (ja) * 1988-05-07 1989-11-22 Zhongguo Yixuekexueyuan Yaowo Yanjiusuo リグナン化合物
CN1562275A (zh) * 2004-03-22 2005-01-12 广州安健实业发展有限公司 野木瓜总甙及其注射剂
KR20110068923A (ko) * 2009-12-15 2011-06-22 재단법인 경기바이오센터 항히스타민제 조성물

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GYUOK LEE，ET AL: "Anti–inflammatory effects of Stauntonia hexaphylla in LPS-Induced Raw 264.7", 《2011年度韩国生物工程春季学术发表大会》 *

Also Published As

Publication number Publication date
AU2016201841A1 (en) 2016-05-19
CA2999174A1 (en) 2013-02-21
EP3097920B1 (en) 2019-07-31
US9370542B2 (en) 2016-06-21
EP2774617A4 (en) 2015-02-18
PL2774617T3 (pl) 2017-08-31
JP6049721B2 (ja) 2016-12-21
JP6258409B2 (ja) 2018-01-10
AU2016201841B2 (en) 2017-11-02
EP2774617A1 (en) 2014-09-10
ES2620022T3 (es) 2017-06-27
WO2013024960A1 (ko) 2013-02-21
CA2999174C (en) 2020-07-14
EP2774617B1 (en) 2016-12-21
CA2845625C (en) 2018-05-15
CA2845625A1 (en) 2013-02-21
US20160193265A1 (en) 2016-07-07
JP2016164202A (ja) 2016-09-08
CN103826651A (zh) 2014-05-28
JP2014524436A (ja) 2014-09-22
US20140205691A1 (en) 2014-07-24
ES2752249T3 (es) 2020-04-03
EP3097920A1 (en) 2016-11-30
PL3097920T3 (pl) 2020-03-31
AU2012295779A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
KR101221617B1 (ko) 멀꿀 잎 추출물을 포함하는 항염증제
KR101116852B1 (ko) 후박 추출물 또는 이로부터 분리된 ４-ｏ-메틸호노키올을유효성분으로 함유하는 항염, 항알러지 및 주름 개선용조성물
KR20190064714A (ko) 레몬머틀 추출물을 유효성분으로 포함하는 항염증제
JP6258409B2 (ja) ムベ抽出物を含む医薬組成物
KR101167589B1 (ko) 멀꿀 열매 추출물을 포함하는 항염증제
KR20130094145A (ko) 개꼬시래기 아임계수 추출물을 유효성분으로 포함하는 항염증제
KR20160069919A (ko) 삼채 추출물을 포함하는 항염증제
KR101702621B1 (ko) 꽃잔디 추출물을 포함하는 항염증제
KR101317668B1 (ko) 멀꿀 잎 추출물을 유효성분으로 포함하는 관절염 치료 또는 예방용 약학 조성물
KR20170000491A (ko) 곰보배추 추출물, 느릅나무 추출물, 노나무 추출물 및 가시오가피 추출물을 유효성분으로 포함하는 알레르기성 비염 예방 및 코막힘 치료용 조성물
KR101185903B1 (ko) 등골나물 추출물을 포함하는 항염증제
KR20190038702A (ko) 다시마 발효물을 유효성분으로 포함하는 항염증제
KR102184670B1 (ko) 진세노사이드 Rg3을 포함하는 항염증 조성물
KR102137144B1 (ko) 피라칸타 잎 추출물을 포함하는 항염증용 조성물
KR20130032995A (ko) 타마린드 추출물을 유효성분으로 포함하는 항염증 활성을 갖는 조성물
KR102816690B1 (ko) 모링가 잎, 창포 전초 및 구기자 열매의 발효 추출물을 유효성분으로 포함하는 항산화 또는 항염증용 화장료 조성물
KR102547208B1 (ko) 인삼 추출물의 컬럼 정제 분획물을 포함하는 피부면역 강화용 조성물
KR101793013B1 (ko) 푸미트레모르진 b를 유효성분으로 포함하는 퇴행성 뇌질환 치료 또는 예방용 조성물
KR20240170892A (ko) 과민성 면역 반응 개선용 조성물
KR20130013693A (ko) 창포 추출물을 유효성분으로 포함하는 아토피 피부염 예방 및 개선용 외용 조성물
KR20230100953A (ko) 과민성 면역 반응 개선용 조성물
KR20180079623A (ko) 소목 초단파 추출물을 포함하는 항염증제
KR20130099764A (ko) 도금양 추출물을 유효성분으로 포함하는 염증질환 예방 및 치료용 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180814

RJ01 Rejection of invention patent application after publication